Chemed Corporation (NYSE:CHE) Shares Sold by KBC Group NV

KBC Group NV lowered its position in Chemed Corporation (NYSE:CHE - Free Report) by 89.2% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 626 shares of the company's stock after selling 5,183 shares during the period. KBC Group NV's holdings in Chemed were worth $385,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Whipplewood Advisors LLC lifted its holdings in Chemed by 54.5% in the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after purchasing an additional 18 shares in the last quarter. Impact Capital Partners LLC raised its holdings in shares of Chemed by 2.7% during the 1st quarter. Impact Capital Partners LLC now owns 763 shares of the company's stock worth $469,000 after acquiring an additional 20 shares during the period. CBIZ Investment Advisory Services LLC raised its holdings in shares of Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after acquiring an additional 22 shares during the period. CIBC Private Wealth Group LLC raised its holdings in shares of Chemed by 13.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock worth $98,000 after acquiring an additional 22 shares during the period. Finally, KFG Wealth Management LLC raised its holdings in shares of Chemed by 4.6% during the 1st quarter. KFG Wealth Management LLC now owns 525 shares of the company's stock worth $323,000 after acquiring an additional 23 shares during the period. Hedge funds and other institutional investors own 95.85% of the company's stock.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 1,500 shares of the company's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $576.45, for a total transaction of $864,675.00. Following the completion of the sale, the chief executive officer owned 101,197 shares in the company, valued at $58,335,010.65. This represents a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the sale, the executive vice president owned 14,627 shares of the company's stock, valued at $8,454,259.73. This trade represents a 9.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,500 shares of company stock valued at $2,598,450 in the last 90 days. Company insiders own 3.29% of the company's stock.

Chemed Trading Up 1.2%

CHE stock traded up $5.62 during trading on Tuesday, hitting $466.32. 200,175 shares of the company's stock were exchanged, compared to its average volume of 111,676. The business has a 50-day moving average price of $551.27 and a two-hundred day moving average price of $562.07. The stock has a market capitalization of $6.82 billion, a price-to-earnings ratio of 22.71, a PEG ratio of 2.22 and a beta of 0.50. Chemed Corporation has a 52-week low of $457.53 and a 52-week high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The company had revenue of $646.94 million during the quarter, compared to analysts' expectations of $641.78 million. During the same quarter in the previous year, the business earned $5.20 earnings per share. The firm's revenue for the quarter was up 9.8% on a year-over-year basis. On average, equities research analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.43%. The ex-dividend date of this dividend was Thursday, May 29th. Chemed's dividend payout ratio (DPR) is presently 9.74%.

Analyst Ratings Changes

Several brokerages recently issued reports on CHE. Bank of America reduced their price objective on shares of Chemed from $708.00 to $650.00 and set a "buy" rating on the stock in a report on Monday, June 30th. Wall Street Zen lowered shares of Chemed from a "buy" rating to a "hold" rating in a report on Saturday. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $640.00 target price (down from $674.00) on shares of Chemed in a research report on Monday, June 30th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.